Wall Street Journal -- ZURICH (Dow Jones)--Novartis AG (NVS) Thursday reported a sharp rise in second quarter net profit on healthy drug sales and cost cuts, prompting the Swiss drug giant to lift its full-year sales guidance despite a generally difficult market environment in Europe.
